Vivo Bio Tech Ltd.
Snapshot View

36.50 +0.75 ▲2.1%

29 September 2022, 12:34:00 PM
Volume: 3,966

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website
Market Cap 53.41 Cr.
Enterprise Value(EV) 118.24 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 0.86 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 41.79 Trailing Twelve Months Ending 2022-06
Industry PE 30.82 Trailing Twelve Months Ending 2022-06
Book Value / Share 33.28 Trailing Twelve Months Ending 2022-06
Price to Book Value 1.08 Calculated using Price: 35.90
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 1.49 Cr. 14,876,520 Shares
FaceValue 10
Company Profile
Vivo Bio Tech was incorporated on February 12, 1987 as Golden Growth Fund, Hyderabad-based Vivo Bio Tech (VBTL) is a contract research company engaged in biotechnology and pharma drug discovery activities. The company was converted into a public limited company from Jun. 19, 1992. VBTL provides services ranging from insilico design, wet lab contract research, preclinical research and clinical studies spanning the entire drug discovery value chain.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+2.10%
1 Week
-3.31%
1 Month
+14.96%
3 Month
+12.31%
6 Month
-7.83%
1 Year
-54.12%
2 Year
-1.62%
5 Year
-44.27%
10 Year
+244.34%
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) 5.91 3.52 5.25 9.48 22.17 21.01 10.21 14.85 15.36
Return on Capital Employed (%) 7.83 7.95 4.72 5.96 12.39 15.18 9.58 13.85 18.81
Return on Assets (%) 0.83 0.75 1.14 2.09 5.17 5.64 3.92 7.58 8.02

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 8 9 9 10 13 19 27 33 43 45
Non Curr. Liab. 5 5 4 15 22 15 9 9 15 52
Curr. Liab. 26 26 28 20 17 25 19 21 22 24
Minority Int.
Equity & Liab. 39 40 41 46 51 60 55 62 80 122
Non Curr. Assets 21 21 20 24 32 32 30 35 52 96
Curr. Assets 18 19 22 22 20 28 25 27 27 26
Misc. Exp. not W/O 0 0 0 0 0 0 0 0 0
Total Assets 39 40 41 46 51 60 55 62 80 122

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 14 16 18 29 34 47 56 55 52 50
Other Income 1 1 1 1 0 0 0 0 0 0
Total Income 15 17 19 29 35 47 56 55 52 50
Total Expenditure -12 -14 -15 -25 -27 -36 -46 -43 -34 -35
PBIDT 3 3 4 5 8 11 10 13 18 15
Interest -1 0 -1 0 -1 -2 -3 -3 -4 -5
Depreciation -2 -2 -3 -3 -4 -5 -5 -5 -6 -7
Taxation 0 0 0 0 0 -1 0 0 -3 -2
Exceptional Items
PAT 0 0 0 1 3 3 2 4 6 1
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 0 0 0 1 3 3 2 4 6 1
Adjusted EPS 0 0 0 1 3 3 2 3 4 1

Cash Flow View Details >>

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 5 2 3 2 9 -6 11 -1 9 14
Cash Fr. Inv. -5 25 -1 -2 -7 -12 -5 -4 -10 -23
Cash Fr. Finan. 0 -19 0 -1 0 7 -3 1 2 9
Net Change 0 8 1 -1 1 -11 3 -4 0 0
Cash & Cash Eqvt 2 10 11 11 12 1 4 1 1 1

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 34.70 34.70 34.70 36.58 39.84 39.84 39.84 39.67 42.16
Public 65.30 65.30 65.30 63.42 60.16 60.16 60.16 60.33 57.84
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Wed, 28 Sep 2022
Shareholder Meeting / Postal Ballot-Outcome of AGM
Vivo Bio Tech Limited has submitted with the exchange the Proceedings of the 35th Annual General Meeting of the Company held on Wednesday September 28 2022 at 03.00 pm through video conference.
Wed, 07 Sep 2022
Clarification sought from Vivo Bio Tech Ltd
The Exchange has sought clarification from Vivo Bio Tech Ltd on September 6 2022 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.

The reply is awaited.
Wed, 07 Sep 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
Vivo Bio Tech Limited has submitted with the exchange the copies of Newspaper Publication for Notice of 35th Annual General Meeting Book Closure and E-Voting.

Technical Scans View Details >>

Wed, 28 Sep 2022
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
High Increase 1 Month High Increase 1 Month
High Increase 3 Months High Increase 3 Months
High Decrease 1 Year High Decrease 1 Year

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 220,222.96 937.85 +2.2%
Divi's Laboratories Ltd. 98,114.53 3,735.40 +0.9%
Cipla Ltd. 88,495.80 1,113.75 +1.5%
Dr. Reddy's Laboratories Ltd. 71,034.40 4,369.00 +2.3%
Apollo Hospitals Enterprise Ltd. 61,344.29 4,371.80 +2.4%
Torrent Pharmaceuticals Ltd. 50,536.67 1,534.90 +2.7%
Alkem Laboratories Ltd. 39,477.37 3,192.75 -3.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.55 937.85 +2.2%
Divi's Laboratories Ltd. Consolidated 2022-06 31.60 3,735.40 +0.9%
Cipla Ltd. Consolidated 2022-06 35.56 1,113.75 +1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.75 4,369.00 +2.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 69.44 4,371.80 +2.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 63.09 1,534.90 +2.7%
Alkem Laboratories Ltd. Consolidated 2022-06 30.25 3,192.75 -3.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.39 937.85 +2.2%
Divi's Laboratories Ltd. Consolidated 2022-06 7.89 3,735.40 +0.9%
Cipla Ltd. Consolidated 2022-06 4.12 1,113.75 +1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.51 4,369.00 +2.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.32 4,371.80 +2.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 7.91 1,534.90 +2.7%
Alkem Laboratories Ltd. Consolidated 2022-06 4.50 3,192.75 -3.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 937.85 +2.2%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,735.40 +0.9%
Cipla Ltd. Consolidated 2022-03 0.04 1,113.75 +1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,369.00 +2.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,371.80 +2.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,534.90 +2.7%
Alkem Laboratories Ltd. Consolidated 2022-03 0.30 3,192.75 -3.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 937.85 +2.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,735.40 +0.9%
Cipla Ltd. Consolidated 2022-03 13.10 1,113.75 +1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,369.00 +2.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.80 +2.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,534.90 +2.7%
Alkem Laboratories Ltd. Consolidated 2022-03 20.99 3,192.75 -3.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 937.85 +2.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,735.40 +0.9%
Cipla Ltd. Consolidated 2022-03 13.10 1,113.75 +1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,369.00 +2.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.80 +2.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,534.90 +2.7%
Alkem Laboratories Ltd. Consolidated 2022-03 20.99 3,192.75 -3.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 937.85 +2.2%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,735.40 +0.9%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,113.75 +1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,369.00 +2.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,371.80 +2.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,534.90 +2.7%
Alkem Laboratories Ltd. Consolidated 2022-03 10,634.19 3,192.75 -3.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 937.85 +2.2%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,735.40 +0.9%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,113.75 +1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,369.00 +2.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,371.80 +2.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,534.90 +2.7%
Alkem Laboratories Ltd. Consolidated 2022-03 1,680.32 3,192.75 -3.2%

FAQ's On Vivo Bio Tech Ltd.

What is Vivo Bio Tech share price?

Can I buy Vivo Bio Tech shares now?

What is the Market Cap of Vivo Bio Tech?

What are the key metrics to analyse Vivo Bio Tech?

What is the 52 Week High and Low of Vivo Bio Tech?

What is the trend of Vivo Bio Tech share price?